Viewing Study NCT01491295


Ignite Creation Date: 2025-12-24 @ 2:06 PM
Ignite Modification Date: 2025-12-30 @ 3:37 AM
Study NCT ID: NCT01491295
Status: UNKNOWN
Last Update Posted: 2016-04-01
First Post: 2011-10-27
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Switch to Tenofovir Versus Continue Lamivudine/Adefovir Treatment in Lamivudine-resistance Chronic Hepatitis B Patients
Sponsor: Taipei Veterans General Hospital, Taiwan
Organization:

Organization Data

Organization:
Class: OTHER_GOV
Study ID: IN-US-174-0194
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor:
Lead Sponsor Class: OTHER_GOV
Responsible Party:
Responsible Party Title:
Responsible Party Type: PRINCIPAL_INVESTIGATOR
Responsible Party Affiliation:
Old Name: None
Old Organization: None

Collaborators

Collaborators

Name Class View
None OTHER View
None OTHER View
None OTHER View
None OTHER View